• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIOMED GMBH & CO. MEDIZINTECHNIK KG LIFESTENT 5F VASCULAR STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIOMED GMBH & CO. MEDIZINTECHNIK KG LIFESTENT 5F VASCULAR STENT SYSTEM Back to Search Results
Catalog Number 5F050603C
Device Problems Positioning Failure (1158); Difficult to Remove (1528); Difficult to Advance (2920)
Patient Problem Injury (2348)
Event Date 07/02/2019
Event Type  Injury  
Manufacturer Narrative
The lot number for the device was provided.The device history records are currently under review.The device has been returned for evaluation.The investigation is currently underway.The catalog number identified has not been cleared in the u.S.But, it is similar to the lifestent 5f vascular stent system products that are cleared in the us.The 510 k number and pro code for the lifestent 5f vascular stent system products are identified.(expiry date: 09/2020), (b)(4).
 
Event Description
It was reported that during treatment of the distal right superficial femoral artery via left humeral tract access, the stent was allegedly difficult to advance to the lesion and failed to deploy due to the delivery system sheath wrinkling.It was further reported that the delivery system was removed with the guidewire as one unit and that no additional stent was implanted.Additional intervention will be required to treat the lesion.
 
Event Description
It was reported that during treatment of the distal right superficial femoral artery via left humeral tract access, the stent was allegedly difficult to advance to the lesion, the handle loosened, and the stent failed to deploy due to the delivery system sheath wrinkling.It was further reported that the delivery system was removed with the guidewire as one unit and that no additional stent was implanted.Additional intervention will be required to treat the lesion.
 
Manufacturer Narrative
H10: manufacturing review: review of manufacturing records was not performed, as no additional complaint has been reported for this lot.Based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.Investigation summary: based on the investigation of the returned catheter sample a deployment failure could not be confirmed because the safety lock slider was found in secured position, and because the stent was fully and correctly loaded.The system was found with compressive crinkles, with a kink and with a gap between the two grip shells which confirmed the users¿ statement that the grip loosened, and that the stent sheath wrinkled on itself.The sample was returned without guidewire so that a stuck guidewire could not be confirmed.The investigation will be closed as confirmed for material deformation.A manufacturing related cause could not be confirmed.A definite root cause for the reported event could not be determined.Labeling review: in reviewing the relevant labeling for this product, it was found that the instructions for use (ifu) sufficiently address this potential risk.Correct holding and handling throughout deployment were found sufficiently described.In regard to release force increase the ifu states: 'do not constrict the delivery system during stent deployment.If excessive force is felt during stent deployment, do not force the stent system.Remove the stent system and replace with a new unit', and 'if resistance is met during stent system introduction, the stent system should be withdrawn, and another stent system should be used.' in regard to pta the ifu states: 'pre-dilatation of the lesion with a balloon dilatation catheter is recommended.' the ifu states that the safety lock slider must be unlocked before use by pulling it back towards the wheels, and that the system requires flushing prior to use.H10: the catalog number identified in section d4 has not been cleared in the u.S.But, it is similar to the lifestent 5f vascular stent system products that are cleared in the us.The 510 k number and pro code for the lifestent 5f vascular stent system products are identified in d2 and g5.H10: d4 (expiry date: 09/2020), h6(device code: 2976 - material deformation).H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIFESTENT 5F VASCULAR STENT SYSTEM
Type of Device
VASCULAR STENT
Manufacturer (Section D)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstrasse 6
karlsruhe 76227
GM  76227
MDR Report Key8847736
MDR Text Key152860975
Report Number9681442-2019-00140
Device Sequence Number1
Product Code NIP
UDI-Device Identifier00801741119897
UDI-Public(01)00801741119897
Combination Product (y/n)N
PMA/PMN Number
P070014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 10/08/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/31/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number5F050603C
Device Lot NumberANCW0640
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/25/2019
Date Manufacturer Received09/24/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-